Pages that link to "Q36349304"

The following pages link to Management of Staphylococcus aureus infections (Q36349304):

Displaying 15 items.

• A high-throughput screen for antibiotic drug discovery (Q33857043) (← links)
• Intra- and extracellular activities of dicloxacillin against Staphylococcus aureus in vivo and in vitro. (Q33876454) (← links)
• Methicillin-resistant Staphylococcus aureus in surgical patients: identification of high-risk populations for the development of targeted screening programmes (Q34511863) (← links)
• Intra- and extracellular activities of dicloxacillin and linezolid against a clinical Staphylococcus aureus strain with a small-colony-variant phenotype in an in vitro model of THP-1 macrophages and an in vivo mouse peritonitis model (Q34737534) (← links)
• Expression of Four Methionine Sulfoxide Reductases in Staphylococcus aureus (Q35681381) (← links)
• Simultaneous and Direct Determination of Vancomycin and Cephalexin in Human Plasma by Using HPLC-DAD Coupled with Second-Order Calibration Algorithms (Q35942538) (← links)
• Intracellular activity of antibiotics against Staphylococcus aureus in a mouse peritonitis model (Q37190843) (← links)
• Multiple ligands of von Willebrand factor-binding protein (vWbp) promote Staphylococcus aureus clot formation in human plasma (Q37201304) (← links)
• Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals. (Q37286901) (← links)
• β-Lactams and β-Lactamase Inhibitors: An Overview (Q38872374) (← links)
• Characteristics of cefazolin inoculum effect-positive methicillin-susceptible staphylococcus aureus infection in a multicentre bacteraemia cohort (Q39313894) (← links)
• Trend of vancomycin susceptibility of staphylococci at a level 1 trauma centre of India (Q42369114) (← links)
• Panton-Valentine Leucocidin (PVL) as a Potential Indicator for Prevalence, Duration, and Severity of Staphylococcus aureus Osteomyelitis (Q47110379) (← links)
• Characterisation of anti-alpha toxin antibody levels and colonisation status after administration of an investigational human monoclonal antibody, MEDI4893, against Staphylococcus aureus alpha toxin (Q50356712) (← links)
• Evaluation of apramycin activity against methicillin-resistant, methicillin-sensitive, and vancomycin-intermediate Staphylococcus aureus clinical isolates (Q89204650) (← links)